Benchmark analyst Bill Sutherland reiterated a Buy rating and $60.00 price target on Nutex Health (NASDAQ: NUTX).The analyst commented, "For ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE